BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28412707)

  • 1. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
    PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria.
    Ahn SS; Lee B; Kim D; Jung SM; Lee SW; Park MC; Park YB; Hwang YG; Song JJ
    PLoS One; 2019; 14(7):e0219970. PubMed ID: 31318961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
    Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
    Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
    Yamabe T; Ohmura SI; Uehara K; Naniwa T
    Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
    Yao H; Wang Y; Wang Z; Zhao J; Deng X; Zhang Z; Zhao Y; Zhang Y; Shu Q; Jia Y; Li ZG
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):129-134. PubMed ID: 34596030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
    Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
    Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
    Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
    Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18.
    Ichida H; Kawaguchi Y; Sugiura T; Takagi K; Katsumata Y; Gono T; Ota Y; Kataoka S; Kawasumi H; Yamanaka H
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):642-6. PubMed ID: 24124073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
    Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.